Aarti Industries
Aarti Industries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
Steady volume growth is expected, supported by capacity expansion and deeper market penetration. - Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets. - Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization. - Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures. - New platforms like battery chemicals and defense applications are being explored based on capability and return profiles. - JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth. - FY27 capex is on track at Rs. Aarti Industries targets EBITDA of INR 1,800 crore by FY28, including contributions from the Augene JV.
From Aarti Industries's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Steady volume growth is expected, supported by capacity expansion and deeper market penetration.
- Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets.
- Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization.
- Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures.
- New platforms like battery chemicals and defense applications are being explored based on capability and return profiles.
- JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Aarti Industries said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Zone IV project expansion is ongoing with 3-6 months delay due to labor and war-related issues; commissioning is phased over FY27 with ramp-up in FY28 and FY29.
- FY27 CAPEX is on track within Rs. 700-800 crore range, with Rs. 180 crore deployed in Q1FY27.
- Future capital deployment will focus on high-growth, high-return niche projects, reducing CAPEX intensity starting FY28.
- Debottlenecking of DCB capacity to 140 KTPA planned, supported by demand for PDCB and downstream products.
- JV with Superform Chemistries (Augene Chemicals) is on track for commissioning in Q2FY27, focusing on specialty chemicals.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Aarti Industries said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Aarti Industries — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.2K Cr, net profit ₹137 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Aarti Industries's management said in earlier quarters
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Frequently Asked Questions
What were Aarti Industries Q1 FY27 results?
Steady volume growth is expected, supported by capacity expansion and deeper market penetration. - Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets. - Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization. - Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures. - New platforms like battery chemicals and defense applications are being explored based on capability and return profiles. - JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth. - FY27 capex is on track at Rs. Aarti Industries targets EBITDA of INR 1,800 crore by FY28, including contributions from the Augene JV.
What is Aarti Industries share price analysis?
Aarti Industries currently shows a below-average growth signal. The stock trades at a P/E of 36.6 with a market cap of ₹19,123 Cr. Investors should review the full earnings analysis for detailed insights.
Is Aarti Industries planning capital expenditure?
Zone IV project expansion is ongoing with 3-6 months delay due to labor and war-related issues; commissioning is phased over FY27 with ramp-up in FY28 and FY29.
Keep Aarti Industries on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.